In recent years, the confluence of Generative Artificial Intelligence (AI) with aging research and drug discovery presents a major opportunity to advance our understanding of the fundamental ...

"For instance, when analyzing rapamycin, a drug often studied for its potential to promote healthy aging, the AI not only evaluated its efficacy but also provided context-specific explanations and ...

According to the AI model, 15,563 participants were found to be experiencing normal aging, 24,671 were experiencing accelerated aging and 23,566 were experiencing decelerated aging. Compared to ...